U.S. Physical Therapy's declining ROCE trend is concerning. Despite reinvestment, returns are shrinking and shareholder returns have been flat over five years. The stock doesn't show multi-bagger traits, suggesting investors may find better options elsewhere.
Investors remain optimistic about U.S. Physical Therapy's robust earnings outlook. The market's high P/E ratio reflects strong future growth expectations for the company, despite the industry average.
The cautious investor sentiment towards the company's future is reflected in declining share price and EPS. A potential stabilization is indicated by a 0.7% TSR gain over past year, albeit below market return.
美國理療保健股票討論區
2023Q1營收增長12.8%,營業利潤增長16.2%,淨利潤繼續受利息費用和其它費用增長影響而下滑了4.6%。
目前價格117.2,市盈率52,市盈率TTM升到了54.3,估值缺乏吸引力。
暫無評論